• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Naturvetenskap och teknik
    2. Teknik och industri
    3. Tillverkningsteknik

    Biological Drug Products

    Development and Strategies

    AvWei Wang,Manmohan Singh

    Inbunden, Engelska, 2013

    2 098 kr

    Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Tested and proven solutions to the challenges of biological drug product developmentBiological drug products play a central role in combating human diseases; however, developing new successful biological drugs presents many challenges, including labor intensive production processes, tighter regulatory controls, and increased market competition. This book reviews the current state of the science, offering readers a single resource that sets forth the fundamentals as well as tested and proven development strategies for biological drugs. Moreover, the book prepares readers for the challenges that typically arise during drug development, offering straightforward solutions to improve their ability to pass through all the regulatory hurdles and deliver new drug products to the market.Biological Drug Products begins with general considerations for the development of any biological drug product and then explores the strategies and challenges involved in the development of specific types of biologics. Divided into five parts, the book examines: Part 1: General AspectsPart 2: Proteins and PeptidesPart 3: VaccinesPart 4: Novel BiologicsPart 5: Product Administration/DeliveryEach chapter has been prepared by one or more leading experts in biological drug development. Contributions are based on a comprehensive review and analysis of the current literature as well as the authors' first-hand experience developing and testing new drugs. References at the end of each chapter serve as a gateway to original research papers and reviews in the field.By incorporating lessons learned and future directions for research, Biological Drug Products enables pharmaceutical scientists and students to improve their success rate in developing new biologics to treat a broad range of human diseases.

    Produktinformation

    • Utgivningsdatum:2013-11-29
    • Mått:155 x 239 x 43 mm
    • Vikt:1 157 g
    • Format:Inbunden
    • Språk:Engelska
    • Antal sidor:744
    • Förlag:John Wiley & Sons Inc
    • ISBN:9781118148891

    Utforska kategorier

    • Tillverkningsteknik inom Naturvetenskap och teknik

    Mer om författaren

    WEI WANG, PhD, is a Research Fellow for Pfizer BioTherapeutics Pharmaceutical Sciences. In addition, Dr. Wang is Adjunct Professor in the School of Pharmacy and Health Sciences at the University of the Pacific.MANMOHAN SINGH, PhD, is Head of Technical Development at Novartis Vaccines and Diagnostics. Dr. Singh has authored over 120 peer-reviewed manuscripts, reviews, and book chapters in the area of vaccine formulations and adjuvant research. He is also an Adjunct Professor at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill.

    Recensioner i media

    “Thus, it will be a valuable resource for both novice and expert alike.” (ChemMedChem, 1 October 2014)

    Innehållsförteckning

    • DedicationPrefacePart 1. General Aspects 1Chapter 1. An Overview of Discovery and Development Process For Biologics 3Heather H. Shih, Paula Miller and Douglas C. HarnishChapter 2. Nonclinical Safety Assessment of Biologics, Including Vaccines 31Liangbiao George Hu, David W. ClarkeChapter 3 Clinical Assessment of Biologics Agents 57Lesley Ann Saketkoo, Shikha Mittoo and Luis R. EspinozaChapter 4. Key Regulatory Guidelines for Development of Biologics In The U.S. And Europe 75Richard Kingham, Gabriela Klasa and Krista Hessler CarverChapter 5. Landscape and Consideration of Intellectual Property for Development Of Biosimilars 111Srikumaran MelethilChapter 6. Scientific Aspects of Sterility Assurance, Sterility, Asepsis, and Sterilization 133James E. Akers and James P. AgallocoPart 2. Proteins/Peptides 163Chapter 7. Cell Cell Culture Processes in Monoclonal Antibody Production 165Feng Li, Amy (Yijuan) Shen and Ashraf AmanullahChapter 8. Protein/Peptide Purification and Virus Reduction 203Beckley K. Nfor, Esteban Freydell and Marcel OttensChapter 9. Chemical and Genetic Modification 233M Farys, C Ginn, G Badescu, K Peciak, E Pawlisz, H Khalili and S BrocchiniChapter 10. Analytical Characterization of Proteins/Peptides 285Yajun Jennifer Wang and Brian HoskenChapter 11. Protein/Peptide Formulation Development 323Satoshi Ohtake and Wei WangChapter 12. Regulatory Strategies and Lessons in the Development Of Biosimilars 367Umang S. ShahPart 3. Vaccines 409Chapter 13. Vaccine Development – History, Current Status and Future Trends 411Leo Van Der Pol and Jean-Pierre AmorijChapter 14. Role and Application of Adjuvants and Delivery Systems in Vaccines 437Rajesh K. GuptaChapter 15. Methods for Characterizing Proteins in Aluminum Adjuvant Formulations 469Martinus A.H. Capelle, Emilie Poirier and Tudor ArvintePart 4. Novel Biologics 487Chapter 16. The State Of The Art and Future of Gene Medicines 489Frank Jacobs, Stephanie C. Gordts and Bart De GeestChapter 17. Nucleic Acid Vaccines 531Rachel Buglione-Corbett, John Suschak, Shixia Wang and Shan LuChapter 18. Multifunctional Polymeric Nano-Systems for Rna Interference Therapy 569Arun Iyer, Shanthi Ganesh, Qiong L. Zhou and Mansoor AmijiChapter 19. Advent and Maturation of Regenerative Medicine 601Abner M. Mhashilkar and Anthony AtalaPart 5. Product Administration/Delivery 629Chapter 20. Conventional and Novel Container Closure/Delivery Systems 631Joseph Wong and Mahesh V. ChaubalChapter 21. Controlled-Release Systems for Biologics 655Mayura Oak, Rhishikesh Mandke, Buddhadev Layek, Gitanjali Sharma and Jagdish SinghChapter 22. Routes of Delivery for Biological Drug Products 677Darrell J. Irvine, Xingfang Su and Brandon Kwong INDEX 725